Home

Jean Jacques Bienaime, Director: Keros Therapeutics KROS Buy · Filed 05/19

Trade details

Type
Insider buy
Amount
$10,580
Shares · price
1,000 sh · $10.58 a share
Held after
9,450 sh
Trade date
26/05/15
Filed
26/05/19
Days to filing
4 days

First buy since 2023

Insiders buying this week
1 insiders
Holding change
+11.8%

Keros Therapeutics trades, last 26 weeks

What else happened in Keros Therapeutics around then

Filed or reported within 30 days of the trade day · 04/15~06/14

Jean Jacques Bienaime's recent trades